Australian Medical Cannabis Market Trends October 2019

Summary

» Number of products in market jumps 40% in 6 months
» Patient growth continues at break-neck speed, up 1000% year on year
» Overall spend declines as doctors go for cheaper products
» Issues around vehicle driving and government subsidies remain

 

Patient Approval Rate Up Over 1000% In 2019

Patient approval numbers in Australia for medical cannabis continues to grow exponentially. July saw 40% growth month on month with a forecasting a total of 28,301 new patient approvals in 2019 – growth of 1023% on the 2500 approvals in 2018.

Medicinal Cannabis Approved Numbers (SASB)

The Medicinal Cannabis Active Patient base is expected to cross 10,000 by end of 2019

Product Competition Continues

There are now 76 medical cannabis products available for doctor prescription in the Australian market – a jump of more than 40% from 54 confirmed by the FreshLeaf Analytics team in Q1 2019.

Number of Medicinal Cannabis products in the Australian Market

 

Oil still dominates the market as the primary delivery mechanism, followed by dried flower, capsules, granulated flowers, spray and crystal.

Medical Cannabis Product types in the Australian market (Q3 2019)

 

 

 

The above insights are from Fresh Leaf Analytics Q3 2019 report.